Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance

BACKGROUND: Application of genetically modified hematopoietic stem cells is increasingly mooted as a clinically relevant approach to protein replacement therapy, immune tolerance induction or conditions where both outcomes may be helpful. Hematopoietic stem and progenitor cell (HSPC)-mediated gene t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Kunal H., Rudraraju, Rajeev, Brooks, Jeremy F., Jung, Ji-Won, Galea, Ryan, Wells, James W., Steptoe, Raymond J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345164/
https://www.ncbi.nlm.nih.gov/pubmed/28279220
http://dx.doi.org/10.1186/s13287-017-0508-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345164/
https://www.ncbi.nlm.nih.gov/pubmed/28279220
http://dx.doi.org/10.1186/s13287-017-0508-3

Ejemplares similares